Le Lézard
Classified in: Health, Business
Subjects: NPT, OTC

RESTANCE to Reveal Major Brand Name and Globally Recognized Logo to go on Condoms Manufactured in Campaign to End AIDS


SPARKS, Nevada, November 21, 2017 /PRNewswire/ --

RESTANCE, Inc. (USOTC: ANCE) today announced the company plans to reveal next week the major brand name and globally recognized logo that will appear on the condoms manufactured by RESTANCE in Africa for the #DoItForAfrica buy-one-give-one campaign anticipated to generate $20 million in revenue. Yesterday, the company announced a $500,000 contract to manufacture condoms under a major brand name for distribution in Africa. The company plans to reveal the "major brand name" on November 28, 2017 in conjunction with a World AIDS Day announcement. The $500,000 contract is part of a strategic campaign that will be announced on November 28, 2017 in conjunction with World AIDS Day on December 1, 2017. The campaign is designed to contribute to the United Nations goal of ending the AIDS Epidemic. RESTANCE plans to contribute to the UN goal to end the AIDS Epidemic by making condoms available everywhere in Africa through the #DoItForAfrica buy-one-give-one campaign where an anticipated $20 million in condoms will be sold in North American and for every condom sold, a condom will be manufactured in Africa and given away in Africa. The contract announced today is the initial commitment for the condoms to be manufactured and given away in Africa.

RESTANCE -  $20 Million Revenue #DoItForAfrica Campaign 
RESTANCE has acquired the tools to equip a condom manufacturing plant and plans to open a condom manufacturing plant in Kenya soon to produce condoms for all Africa. RESTANCE has secured a contract where the company will produce condoms under a major, globally recognized brand name in conjunction with the #DoItForAfrica buy-one-give-one campaign. The #DoItForAfrica campaign is anticipated to generate $20 million in revenue.

RESTANCE is pursuing several business lines in the growing economies of East Africa. The Company is developing opportunities in the region including initiatives in technology and systems integration services, utility support services, affordable housing and health products manufacturing. RESTANCE recently acquired East African Development Partners as part of its strategy in East Africa.

Learn more about the RESTANCE operations in Africa on the Company's website: http://www.restanceinc.com

Disclaimer/Safe Harbor:

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur.

Randell Torno
[email protected]  
+1-800-834-5792

SOURCE RESTANCE, Inc.


These press releases may also interest you

3 mai 2024
Chemistree Technology Inc. and (US OTC: CHMJF) (the "Company" or "Chemistree"), announces that its board of directors (the "Board") has approved a restructuring transaction (the "Restructuring Transaction"), pursuant to which all of the principal of...

3 mai 2024
United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, will unveil its latest MRI technology, boasting incredible advancements across various fronts, as a Gold sponsor at this year's ISMRM meeting. The...

3 mai 2024
In the news release, Mitsubishi Tanabe Pharma America to Present RADICAVA ORS® (edaravone) Real-World Data at the Professional Society for Health Economics and Outcomes Research 2024 Annual Meeting, issued 03-May-2024 by Mitsubishi Tanabe Pharma...

3 mai 2024
Affiliated Dermatologists (AD) is providing notice of a recent data security incident. At this time, AD is not aware of any misuse of any personal information in connection with this incident. What Happened? On March 5, 2024, AD detected it was the...

3 mai 2024
With recent news of dairy cattle in the United States testing positive for the Highly Pathogenic Avian Influenza (HPAI) and reports of fragments of HPAI detected in pasteurized milk sold in the U.S., we understand that Canadians may be concerned...

3 mai 2024
Butterfly Medical Ltd, an early-stage medical device company focused on alleviating suffering in patients with BPH (Benign Prostatic Hyperplasia), is excited to announce the hiring of Patrick MacCarthy as CEO. ...



News published on and distributed by: